Difference between revisions of "Cancer Types"
Jump to navigation
Jump to search
[unchecked revision] | [unchecked revision] |
Bailey.Glen (talk | contribs) |
|||
(24 intermediate revisions by 4 users not shown) | |||
Line 4: | Line 4: | ||
== Common Adult Cancers == | == Common Adult Cancers == | ||
− | #[[AML|Acute Myeloid Leukemia]] | + | #[[:Category:AML|Acute Myeloid Leukemia]] |
− | #[[ | + | #[[:Category:Kidney|Neoplasms of the Kidney]] |
+ | #[[:Category:Brain|Neoplasms of the Brain and CNS]] | ||
== Common Pediatric Cancers == | == Common Pediatric Cancers == | ||
Line 295: | Line 296: | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
: Malignant epithelial tumours | : Malignant epithelial tumours | ||
− | : Squamous cell carcinoma | + | : [[Squamous cell carcinoma]] |
− | : Lymphoepithelial carcinoma | + | : [[Lymphoepithelial carcinoma]] |
− | : Sinonasal undifferentiated carcinoma | + | : [[Sinonasal undifferentiated carcinoma]] |
− | : Adenocarcinoma | + | : [[Adenocarcinoma]] |
− | : Salivary gland-type carcinomas | + | : [[Salivary gland-type carcinomas]] |
− | : Neuroendocrine tumours | + | : [[Neuroendocrine tumours]] |
− | : Benign epithelial tumours | + | : [[Benign epithelial tumours]] |
− | : Schneiderian papillomas | + | : [[Schneiderian papillomas]] |
− | : Respiratory epithelial adenomatoid hamartoma | + | : [[Respiratory epithelial adenomatoid hamartoma]] |
− | : Salivary gland-type adenomas | + | : [[Salivary gland-type adenomas]] |
− | : Soft tissue tumours | + | : [[Soft tissue tumours]] |
− | : Malignant soft tissue tumours | + | : [[Malignant soft tissue tumours]] |
− | : Borderline and LMP tumours | + | : [[Borderline and LMP tumours]] |
− | : Benign soft tissue tumours | + | : [[Benign soft tissue tumours]] |
− | : Tumours of bone and cartilage | + | : [[Tumours of bone and cartilage]] |
− | : Malignant tumours | + | : [[Malignant tumours]] |
− | : Benign tumours | + | : [[Benign tumours]] |
− | : Haematolymphoid tumours | + | : [[Haematolymphoid tumours]] |
− | : Neuroectodermal tumours | + | : [[Neuroectodermal tumours]] |
− | : Germ cell tumours | + | : [[Germ cell tumours]] |
− | : Secondary tumours | + | : [[Secondary tumours]] |
</div> | </div> | ||
</div> | </div> | ||
Line 646: | Line 647: | ||
'''Special subtypes''' | '''Special subtypes''' | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
− | : Invasive lobular carcinoma | + | : [[Invasive lobular carcinoma]] |
− | : Tubular carcinoma and cribriform carcinoma | + | : [[Tubular carcinoma]] and [[cribriform carcinoma]] |
− | : Carcinoma with medullary features | + | : [[Carcinoma with medullary features]] |
− | : Metaplastic carcinoma | + | : [[Metaplastic carcinoma]] |
− | : Carcinoma with apocrine differentiation | + | : [[Carcinoma with apocrine differentiation]] |
− | : Salivary gland/skin adnexal type tumors | + | : [[Salivary gland/skin adnexal type tumors]] |
− | : Adenoid cystic carcinoma | + | : [[Adenoid cystic carcinoma]] |
− | : Mucoepidermoid carcinoma | + | : [[Mucoepidermoid carcinoma]] |
− | : Polymorphous carcinoma | + | : [[Polymorphous carcinoma]] |
− | : Mucinous carcinoma and | + | : [[Mucinous carcinoma]] and [[Carcinoma with signet-ring-cell differentiation]] |
− | + | : [[Carcinoma with neuroendocrine features]] | |
− | : Invasive papillary carcinoma | + | : [[Invasive papillary carcinoma]] |
− | : Invasive micropapillary carcinoma | + | : [[Invasive micropapillary carcinoma]] |
− | : Inflammatory carcinoma | + | : [[Inflammatory carcinoma]] |
: Bilateral breast carcinoma and non-synchronous breast carcinoma | : Bilateral breast carcinoma and non-synchronous breast carcinoma | ||
− | : Secretory carcinoma | + | : [[Secretory carcinoma]] |
− | : Oncocytic carcinoma | + | : [[Oncocytic carcinoma]] |
− | : Sebaceous carcinoma | + | : [[Sebaceous carcinoma]] |
− | : Lipid-rich carcinoma | + | : [[Lipid-rich carcinoma]] |
− | : Glycogen-rich clear cell carcinoma | + | : [[Glycogen-rich clear cell carcinoma]] |
− | : Acinic cell carcinoma | + | : [[Acinic cell carcinoma]] |
</div> | </div> | ||
</div> | </div> | ||
Line 678: | Line 679: | ||
: Columnar cell lesions | : Columnar cell lesions | ||
: Atypical ductal hyperplasia | : Atypical ductal hyperplasia | ||
− | : Ductal carcinoma in situ | + | : [[Ductal carcinoma in situ]] |
</div> | </div> | ||
</div> | </div> | ||
Line 687: | Line 688: | ||
'''Intraductal papillary lesions''' | '''Intraductal papillary lesions''' | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
− | : Intraductal papilloma | + | : [[Intraductal papilloma]] |
− | : Intraductal papillary carcinoma | + | : [[Intraductal papillary carcinoma]] |
− | : Encapsulated papillary carcinoma | + | : [[Encapsulated papillary carcinoma]] |
− | : Solid papillary carcinoma | + | : [[Solid papillary carcinoma]] |
</div> | </div> | ||
</div> | </div> | ||
Line 697: | Line 698: | ||
'''Benign epithelial proliferations''' | '''Benign epithelial proliferations''' | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
− | : Adenosis, sclerosing adenosis and | + | : Adenosis, sclerosing adenosis and apocrine adenosis |
− | + | : [[Microglandular adenosis]],[[atypical microglandular adenosis and microglandular adenosis with carcinoma]] | |
− | : Microglandular adenosis, | + | : [[Radial scar and complex sclerosing lesion]] |
− | + | : [[Tubular adenoma]] | |
− | |||
− | : Radial scar and complex sclerosing lesion | ||
− | : Tubular adenoma | ||
: Lactating adenoma | : Lactating adenoma | ||
: Apocrine adenoma | : Apocrine adenoma | ||
Line 714: | Line 712: | ||
'''Myoepithelial and epithelial–myoepithelial lesions''' | '''Myoepithelial and epithelial–myoepithelial lesions''' | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
− | : Myoepithelial and epithelial–myoepithelial lesions | + | : [[Myoepithelial and epithelial–myoepithelial lesions]] |
− | : Adenomyoepithelioma and adenomyoepithelioma with carcinoma | + | : [[Adenomyoepithelioma and adenomyoepithelioma with carcinoma]] |
</div> | </div> | ||
</div> | </div> | ||
Line 724: | Line 722: | ||
: Nodular fasciitis | : Nodular fasciitis | ||
: Benign vascular lesions | : Benign vascular lesions | ||
− | : Pseudoangiomatous stromal hyperplasia | + | : [[Pseudoangiomatous stromal hyperplasia]] |
− | : Myofibroblastoma | + | : [[Myofibroblastoma]] |
− | : Desmoid-type fibromatosis | + | : [[Desmoid-type fibromatosis]] |
: Inflammatory myofibroblastic tumour | : Inflammatory myofibroblastic tumour | ||
: Lipoma | : Lipoma | ||
: Granular cell tumour and benign peripheral | : Granular cell tumour and benign peripheral | ||
: nerve-sheath tumour | : nerve-sheath tumour | ||
− | : Angiosarcoma | + | : [[Angiosarcoma]] |
: Liposarcoma | : Liposarcoma | ||
: Rhabdomyosarcoma | : Rhabdomyosarcoma | ||
Line 742: | Line 740: | ||
'''Fibroepithelial tumors''' | '''Fibroepithelial tumors''' | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
− | : Fibroadenoma | + | : [[Fibroadenoma]] |
− | : Phyllodes tumour | + | : [[Phyllodes tumour]] |
: Hamartoma | : Hamartoma | ||
</div> | </div> | ||
Line 753: | Line 751: | ||
: Nipple adenoma | : Nipple adenoma | ||
: Syringomatous tumour | : Syringomatous tumour | ||
− | : Paget disease | + | : [[Paget disease]] |
</div> | </div> | ||
</div> | </div> | ||
Line 760: | Line 758: | ||
'''Lymphoid and haematopoietic tumors''' | '''Lymphoid and haematopoietic tumors''' | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
− | : Diffuse large B-cell lymphoma | + | : [[Diffuse large B-cell lymphoma]] |
: Burkitt lymphoma | : Burkitt lymphoma | ||
: T-cell lymphoma | : T-cell lymphoma | ||
Line 773: | Line 771: | ||
'''Tumors of the male breast''' | '''Tumors of the male breast''' | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
− | : Gynaecomastia | + | : [[Gynaecomastia]] |
− | : Carcinoma of the male breast | + | : [[Carcinoma of the male breast]] |
</div> | </div> | ||
</div> | </div> | ||
Line 782: | Line 780: | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
: Inherited syndromes associated with an increased risk of breast cancer: Introduction | : Inherited syndromes associated with an increased risk of breast cancer: Introduction | ||
− | : BRCA1 and BRCA2 | + | : [[BRCA1 symdrome]] and [[BRCA2 syndrome]] |
− | : Li-Fraumeni syndrome | + | : [[Li-Fraumeni syndrome]] |
: Ataxia telangiectasia syndrome | : Ataxia telangiectasia syndrome | ||
: Cowden syndrome | : Cowden syndrome | ||
Line 797: | Line 795: | ||
== WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (2008) == | == WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (2008) == | ||
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
− | '''Hematological and Lymphoid Neoplasms''' | + | '''[[Hematological and Lymphoid Neoplasms]]''' |
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
− | '''Myeloproliferative neoplasms''' | + | '''[[Myeloproliferative neoplasms]]''' |
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
− | :Chronic myelogenous leukaemia, BCR-ABL1 positive | + | :[[Chronic myelogenous leukaemia, BCR-ABL1 positive]] |
− | :Chronic neutrophilic leukaemia | + | :[[Chronic neutrophilic leukaemia]] |
− | :Polycythaemia vera | + | :[[Polycythaemia vera]] |
− | :Primary myelofibrosis | + | :[[Primary myelofibrosis]] |
− | :Essential thrombocythaemia | + | :[[Essential thrombocythaemia]] |
− | :Chronic eosinophilic leukaemia, NOS | + | :[[Chronic eosinophilic leukaemia, NOS]] |
− | :Mastocytosis | + | :[[HAEM4:Mastocytosis]] |
− | :Cutaneous mastocytosis | + | :[[Cutaneous mastocytosis]] |
− | :Systemic mastocytosis | + | :[[Systemic mastocytosis]] |
− | :Mast cell leukaemia | + | :[[Mast cell leukaemia]] |
− | :Mast cell sarcoma | + | :[[Mast cell sarcoma]] |
− | :Extracutaneous mastocytoma | + | :[[Extracutaneous mastocytoma]] |
− | :Myeloproliferative neoplasm, unclassifiable | + | :[[Myeloproliferative neoplasm, unclassifiable]] |
</div> | </div> | ||
</div> | </div> | ||
− | '''Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA,PDGFRB or FGFR1''' | + | '''[[Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA,PDGFRB or FGFR1]] |
+ | ''' | ||
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
− | '''Myelodysplastic/myeloproliferative neoplasms''' | + | '''[[Myelodysplastic/myeloproliferative neoplasms]]''' |
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
− | :Chronic myelomonocytic leukaemia | + | :[[Chronic myelomonocytic leukaemia]] |
− | :Atypical chronic myeloid leukaemia, BCR-ABL1 negative | + | :[[Atypical chronic myeloid leukaemia, BCR-ABL1 negative]] |
− | :Juvenile myelomonocytic leukaemia | + | :[[Juvenile myelomonocytic leukaemia]] |
− | :Myelodysplastic/myeloproliferative neoplasm, unclassifiable | + | :[[Myelodysplastic/myeloproliferative neoplasm, unclassifiable]] |
</div> | </div> | ||
</div> | </div> | ||
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
− | '''Myelodysplastic syndromes''' | + | '''[[Myelodysplastic syndromes]]''' |
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
− | :Myelodysplastic syndromes/neoplasms, overview | + | :[[Myelodysplastic syndromes/neoplasms, overview]] |
− | :Refractory cytopenia with unilineage dysplasia | + | :[[Refractory cytopenia with unilineage dysplasia]] |
− | :Refractory anaemia with ring sideroblasts | + | :[[Refractory anaemia with ring sideroblasts]] |
− | :Refractory cytopenia with multilineage dysplasia | + | :[[Refractory cytopenia with multilineage dysplasia]] |
− | :Refractory anaemia with excess blasts | + | :[[Refractory anaemia with excess blasts]] |
− | :Myelodysplastic syndrome with isolated del(5q) | + | :[[Myelodysplastic syndrome with isolated del(5q)]] |
− | :Myelodysplastic syndrome, unclassifiable | + | :[[Myelodysplastic syndrome, unclassifiable]] |
− | :Childhood myelodysplastic syndrome | + | :[[Childhood myelodysplastic syndrome]] |
− | :Refractory cytopenia of childhood | + | :[[Refractory cytopenia of childhood]] |
</div> | </div> | ||
</div> | </div> | ||
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
− | '''Acute myeloid leukaemia (AML) and related precursor neoplasms''' | + | '''[[Acute myeloid leukaemia (AML) and related precursor neoplasms]]''' |
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
− | :AML with recurrent genetic abnormalities | + | :[[AML with recurrent genetic abnormalities]] |
− | :AML with t(8;21)(q22;q22); RUNX1-RUNX1T1 | + | :[[AML with t(8;21)(q22;q22); RUNX1-RUNX1T1]] |
− | :AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 | + | :[[AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11]] |
− | :Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA | + | :[[Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA]] |
− | :AML with t(9;11)(p22;q23); MLLT3-MLL | + | :[[AML with t(9;11)(p22;q23); MLLT3-MLL]] |
− | :AML with t(6;9)(p23;q34); DEK-NUP214 | + | :[[AML with t(6;9)(p23;q34); DEK-NUP214]] |
− | :AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2);RPN1-EVI1 | + | :[[AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2);RPN1-EVI1]] |
− | :AML (megakaryoblastic) with t(1;22)(p13;q13);RBM15-MKL1 | + | :[[AML (megakaryoblastic) with t(1;22)(p13;q13);RBM15-MKL1]] |
− | :AML with mutated NPM1 | + | :[[AML with mutated NPM1]] |
− | :AML with mutated CEBPA | + | :[[AML with mutated CEBPA]] |
− | :AML with myelodysplasia-related changes | + | :[[AML with myelodysplasia-related changes]] |
− | :Therapy-related myeloid neoplasms | + | :[[Therapy-related myeloid neoplasms]] |
− | :Acute myeloid leukaemia, NOS | + | :[[Acute myeloid leukaemia, NOS]] |
− | :AML with minimal differentiation | + | :[[AML with minimal differentiation]] |
− | :AML without maturation | + | :[[AML without maturation]] |
− | :AML with maturation | + | :[[AML with maturation]] |
− | :Acute myelomonocytic leukaemia | + | :[[Acute myelomonocytic leukaemia]] |
− | :Acute monoblastic and monocytic leukaemia | + | :[[Acute monoblastic and monocytic leukaemia]] |
− | :Acute erythroid leukaemia | + | :[[Acute erythroid leukaemia]] |
− | :Acute megakaryoblastic leukaemia | + | :[[Acute megakaryoblastic leukaemia]] |
− | :Acute basophilic leukaemia | + | :[[Acute basophilic leukaemia]] |
− | :Acute panmyelosis with myelofibrosis | + | :[[Acute panmyelosis with myelofibrosis]] |
− | :Myeloid sarcoma | + | :[[Myeloid sarcoma]] |
− | :Myeloid proliferations related to Down syndrome | + | :[[Myeloid proliferations related to Down syndrome]] |
− | :Transient abnormal myelopoiesis | + | :[[Transient abnormal myelopoiesis]] |
− | :Myeloid leukaemia associated with Down syndrome | + | :[[Myeloid leukaemia associated with Down syndrome]] |
− | :Blastic plasmacytoid dendritic cell neoplasm | + | :[[Blastic plasmacytoid dendritic cell neoplasm]] |
</div> | </div> | ||
</div> | </div> | ||
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
− | '''Acute leukaemias of ambiguous lineage''' | + | '''[[Acute leukaemias of ambiguous lineage]]''' |
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
− | :Acute undifferentiated leukaemia | + | :[[Acute undifferentiated leukaemia]] |
− | :Mixed phenotype acute leukaemia with t(9;22)(q34;q11.2); BCR-ABL1 | + | :[[Mixed phenotype acute leukaemia with t(9;22)(q34;q11.2); BCR-ABL1]] |
− | :Mixed phenotype acute leukaemia with t(v;11q23); MLL rearranged | + | :[[Mixed phenotype acute leukaemia with t(v;11q23); MLL rearranged]] |
− | :Mixed phenotype acute leukaemia, B/myeloid, NOS 152 | + | :[[Mixed phenotype acute leukaemia, B/myeloid, NOS]] 152 |
− | :Mixed phenotype acute leukaemia, T/myeloid, NOS 153 | + | :[[Mixed phenotype acute leukaemia, T/myeloid, NOS]] 153 |
− | :Mixed phenotype acute leukaemia, NOS - rare types | + | :[[Mixed phenotype acute leukaemia, NOS - rare types]] |
− | :Other ambiguous lineage leukaemias | + | :[[Other ambiguous lineage leukaemias]] |
− | :Natural killer (NK)-cell lymphoblastic leukaemia/lymphoma | + | :[[Natural killer (NK)-cell lymphoblastic leukaemia/lymphoma]] |
</div> | </div> | ||
</div> | </div> | ||
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
− | '''Precursor lymphoid neoplasms''' | + | '''[[Precursor lymphoid neoplasms]]''' |
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
− | :B lymphoblastic leukaemia/lymphoma, NOS | + | :[[B lymphoblastic leukaemia/lymphoma, NOS]] |
− | :B lymphoblastic leukaemia/lymphoma with recurrent genetic abnormalities | + | :[[B lymphoblastic leukaemia/lymphoma with recurrent genetic abnormalities]] |
− | :B lymphoblastic leukaemia/lymphoma with t(9:22)(q34;q11.2); BCR-ABL1 | + | :[[B lymphoblastic leukaemia/lymphoma with t(9:22)(q34;q11.2); BCR-ABL1]] |
− | :B lymphoblastic leukaemia/lymphoma with t(v;11q23); MLL rearranged | + | :[[B lymphoblastic leukaemia/lymphoma with t(v;11q23); MLL rearranged]] |
− | :B lymphoblastic leukaemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1) | + | :[[B lymphoblastic leukaemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)]] |
− | :B lymphoblastic leukaemia/lymphoma with hyperdiploidy | + | :[[B lymphoblastic leukaemia/lymphoma with hyperdiploidy]] |
− | :B lymphoblastic leukaemia/lymphoma with hypodiploidy (Hypodiploid ALL) | + | :[[B lymphoblastic leukaemia/lymphoma with hypodiploidy (Hypodiploid ALL)]] |
− | :B lymphoblastic leukaemia/lymphoma with t(5;14)(q31;q32); IL3-IGH | + | :[[B lymphoblastic leukaemia/lymphoma with t(5;14)(q31;q32); IL3-IGH]] |
− | :B lymphoblastic leukaemia/lymphoma with t(1;19) (q23;p13.3); E2A-PBX1(TCF3-PBX1) | + | :[[B lymphoblastic leukaemia/lymphoma with t(1;19) (q23;p13.3); E2A-PBX1(TCF3-PBX1)]] |
− | :T lymphoblastic leukaemia/lymphoma | + | :[[T lymphoblastic leukaemia/lymphoma]] |
</div> | </div> | ||
</div> | </div> | ||
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
− | '''Mature B-cell neoplasms''' | + | '''[[Mature B-cell neoplasms]]''' |
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
− | :Chronic lymphocytic leukaemia /small lymphocytic lymphoma | + | :[[Chronic lymphocytic leukaemia /small lymphocytic lymphoma]] |
− | :B-cell prolymphocytic leukaemia | + | :[[B-cell prolymphocytic leukaemia]] |
− | :Splenic marginal zone lymphoma | + | :[[Splenic marginal zone lymphoma]] |
− | :Hairy cell leukaemia | + | :[[Hairy cell leukaemia]] |
− | :Splenic B-cell lymphoma/leukaemia, unclassifiable | + | :[[Splenic B-cell lymphoma/leukaemia, unclassifiable]] |
− | :Splenic diffuse red pulp small B-cell lymphoma | + | :[[Splenic diffuse red pulp small B-cell lymphoma]] |
− | :Hairy cell leukaemia-variant | + | :[[Hairy cell leukaemia-variant]] |
− | :Lymphoplasmacytic lymphoma | + | :[[Lymphoplasmacytic lymphoma]] |
− | :Heavy chain diseases | + | :[[Heavy chain diseases]] |
− | :Gamma heavy chain disease | + | :[[Gamma heavy chain disease]] |
− | :Mu heavy chain disease | + | :[[Mu heavy chain disease]] |
− | :Alpha heavy chain disease | + | :[[Alpha heavy chain disease]] |
− | :Plasma cell neoplasms | + | :[[Plasma cell neoplasms]] |
− | :Monoclonal gammopathy of undetermined significance (MGUS) | + | :[[Monoclonal gammopathy of undetermined significance (MGUS)]] |
− | :Plasma cell myeloma | + | :[[Plasma cell myeloma]] |
− | :Solitary plasmacytoma of bone | + | :[[Solitary plasmacytoma of bone]] |
− | :Extraosseous plasmacytoma | + | :[[Extraosseous plasmacytoma]] |
− | :Monoclonal immunoglobulin deposition diseases | + | :[[Monoclonal immunoglobulin deposition diseases]] |
− | :Extranodal marginal zone lymphoma of mucosa- associated lymphoid tissue (MALT lymphoma) | + | :[[Extranodal marginal zone lymphoma of mucosa- associated lymphoid tissue (MALT lymphoma)]] |
− | :Nodal marginal zone lymphoma | + | :[[Nodal marginal zone lymphoma]] |
− | :Follicular lymphoma | + | :[[Follicular lymphoma]] |
− | :Primary cutaneous follicle centre lymphoma | + | :[[Primary cutaneous follicle centre lymphoma]] |
− | :Mantle cell lymphoma | + | :[[Mantle cell lymphoma]] |
− | :Diffuse large B-cell lymphoma (DLBCL), NOS | + | :[[Diffuse large B-cell lymphoma (DLBCL), NOS]] |
− | :T cell/histiocyte-rich large B-cell lymphoma | + | :[[T cell/histiocyte-rich large B-cell lymphoma]] |
− | :Primary DLBCL of the CNS | + | :[[Primary DLBCL of the CNS]] |
− | :Primary cutaneous DLBCL, leg type | + | :[[Primary cutaneous DLBCL, leg type]] |
− | :EBV positive DLBCL of the elderly | + | :[[EBV positive DLBCL of the elderly]] |
− | :DLBCL associated with chronic inflammation | + | :[[DLBCL associated with chronic inflammation]] |
− | :Lymphomatoid granulomatosis | + | :[[Lymphomatoid granulomatosis]] |
− | :Primary mediastinal (thymic) large B-cell lymphoma | + | :[[Primary mediastinal (thymic) large B-cell lymphoma]] |
− | :Intravascular large B-cell lymphoma | + | :[[Intravascular large B-cell lymphoma]] |
− | :ALK positive large B-cell lymphoma | + | :[[ALK positive large B-cell lymphoma]] |
− | :Plasmablastic lymphoma | + | :[[Plasmablastic lymphoma]] |
− | :Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease | + | :[[Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease]] |
− | :Primary effusion lymphoma | + | :[[Primary effusion lymphoma]] |
− | :Burkitt lymphoma | + | :[[Burkitt lymphoma]] |
− | :B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma | + | :[[B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma]] |
− | :B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma | + | :[[B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma]] |
</div> | </div> | ||
</div> | </div> | ||
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
− | '''Mature T- and NK-cell neoplasms''' | + | '''[[Mature T- and NK-cell neoplasms]]''' |
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
− | :T-cell prolymphocytic leukaemia | + | :[[T-cell prolymphocytic leukaemia]] |
− | :T-cell large granular lymphocytic leukaemia | + | :[[T-cell large granular lymphocytic leukaemia]] |
− | :Chronic lymphoproliferative disorder of NK cells | + | :[[Chronic lymphoproliferative disorder of NK cells]] |
− | :Aggressive NK cell leukaemia | + | :[[Aggressive NK cell leukaemia]] |
− | :Epstein-Barr virus (EBV) positive T-cell lymphoproliferative diseases of childhood | + | :[[Epstein-Barr virus (EBV) positive T-cell lymphoproliferative diseases of childhood]] |
− | :Systemic EBV+ T-cell lymphoproliferative disease of childhood | + | :[[Systemic EBV+ T-cell lymphoproliferative disease of childhood]] |
− | :Hydroa vacciniforme-like lymphoma | + | :[[Hydroa vacciniforme-like lymphoma]] |
− | :Adult T-cell leukaemia/lymphoma | + | :[[Adult T-cell leukaemia/lymphoma]] |
− | :Extranodal NK/T-cell lymphoma, nasal type | + | :[[Extranodal NK/T-cell lymphoma, nasal type]] |
− | :Enteropathy-associated T-cell lymphoma | + | :[[Enteropathy-associated T-cell lymphoma]] |
− | :Hepatosplenic T-cell lymphoma | + | :[[Hepatosplenic T-cell lymphoma]] |
− | :Subcutaneous panniculitis-like T-cell lymphoma | + | :[[Subcutaneous panniculitis-like T-cell lymphoma]] |
− | :Mycosis fungoides | + | :[[Mycosis fungoides]] |
− | :Sézary syndrome | + | :[[Sézary syndrome]] |
− | :Primary cutaneous CD30 positive T-cell lymphoproliferative disorders | + | :[[Primary cutaneous CD30 positive T-cell lymphoproliferative disorders]] |
− | :Primary cutaneous peripheral T-cell lymphomas, rare subtypes | + | :[[Primary cutaneous peripheral T-cell lymphomas, rare subtypes]] |
− | :Primary cutaneous gamma-delta T-cell lymphoma | + | :[[Primary cutaneous gamma-delta T-cell lymphoma]] |
− | :Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma | + | :[[Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma]] |
− | :Primary cutaneous CD4 positive small/medium T-cell lymphoma | + | :[[Primary cutaneous CD4 positive small/medium T-cell lymphoma]] |
− | :Peripheral T-cell lymphoma, NOS | + | :[[Peripheral T-cell lymphoma, NOS]] |
− | :Angioimmunoblastic T-cell lymphoma | + | :[[Angioimmunoblastic T-cell lymphoma]] |
− | :Anaplastic large cell lymphoma, ALK positive | + | :[[Anaplastic large cell lymphoma, ALK positive]] |
− | :Anaplastic large cell lymphoma, ALK negative | + | :[[Anaplastic large cell lymphoma, ALK negative]] |
</div> | </div> | ||
</div> | </div> | ||
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
− | '''Hodgkin lymphoma''' | + | '''[[Hodgkin lymphoma]]''' |
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
− | :Nodular lymphocyte predominant Hodgkin lymphoma | + | :[[Nodular lymphocyte predominant Hodgkin lymphoma]] |
− | :Classical Hodgkin lymphoma | + | :[[Classical Hodgkin lymphoma]] |
− | :Nodular sclerosis classical Hodgkin lymphoma | + | :[[Nodular sclerosis classical Hodgkin lymphoma]] |
− | :Mixed cellularity classical Hodgkin lymphoma | + | :[[Mixed cellularity classical Hodgkin lymphoma]] |
− | :Lymphocyte-rich classical Hodgkin lymphoma | + | :[[Lymphocyte-rich classical Hodgkin lymphoma]] |
− | :Lymphocyte-depleted classical Hodgkin lymphoma | + | :[[Lymphocyte-depleted classical Hodgkin lymphoma]] |
</div> | </div> | ||
</div> | </div> | ||
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
− | '''Immunodeficiency-associated lymphoproliferative disorders''' | + | '''[[Immunodeficiency-associated lymphoproliferative disorders]]''' |
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
− | :Lymphoproliferative diseases associated with primary immune disorders | + | :[[Lymphoproliferative diseases associated with primary immune disorders]] |
− | :Lymphomas associated with HIV infection | + | :[[Lymphomas associated with HIV infection]] |
− | :Post-transplant lymphoproliferative disorders (PTLD) | + | :[[Post-transplant lymphoproliferative disorders (PTLD)]] |
− | :Plasmacytic hyperplasia and infectious- mononucleosis-like PTLD | + | :[[Plasmacytic hyperplasia and infectious- mononucleosis-like PTLD]] |
− | :Polymorphic PTLD | + | :[[Polymorphic PTLD]] |
− | :Monomorphic PTLD | + | :[[Monomorphic PTLD]] |
− | :Classical Hodgkin lymphoma type PTLD | + | :[[Classical Hodgkin lymphoma type PTLD]] |
− | :Other iatrogenic immunodeficiency-associated lymphoproliferative disorders | + | :[[Other iatrogenic immunodeficiency-associated lymphoproliferative disorders]] |
</div> | </div> | ||
</div> | </div> | ||
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
− | '''Histiocytic and dendritic cell neoplasms''' | + | '''[[Histiocytic and dendritic cell neoplasms]]''' |
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
− | :Histiocytic sarcoma | + | :[[Histiocytic sarcoma]] |
− | :Tumours derived from Langerhans cells | + | :[[Tumours derived from Langerhans cells]] |
− | :Langerhans cell histiocytosis | + | :[[Langerhans cell histiocytosis]] |
− | :Langerhans cell sarcoma | + | :[[Langerhans cell sarcoma]] |
− | :Interdigitating dendritic cell sarcoma | + | :[[Interdigitating dendritic cell sarcoma]] |
− | :Follicular dendritic cell sarcoma | + | :[[Follicular dendritic cell sarcoma]] |
− | :Other rare dendritic cell tumours | + | :[[Other rare dendritic cell tumours]] |
− | :Disseminated juvenile xanthogranuloma | + | :[[Disseminated juvenile xanthogranuloma]] |
</div> | </div> | ||
</div> | </div> | ||
Line 1,020: | Line 1,019: | ||
: [[Acute Lymphoblastic Leukaemia (ALL)]] | : [[Acute Lymphoblastic Leukaemia (ALL)]] | ||
: [[Acute Myeloid Leukaemia (AML)]] | : [[Acute Myeloid Leukaemia (AML)]] | ||
− | ::[[Acute | + | ::[[HAEM5:Acute megakaryoblastic leukaemia]] |
: [[Adrenal cortical carcinoma]] | : [[Adrenal cortical carcinoma]] | ||
: [[Anal Cancer]] | : [[Anal Cancer]] |
Latest revision as of 13:56, 12 December 2023
These classifications are based on WHO/IARC guidelines. See [1] for further details.
Common Adult Cancers
Common Pediatric Cancers
WHO Classification of Tumours of the Central Nervous System (2016)
Expand
CNS Tumors
WHO Classification of Pathology and Genetics of Head and Neck Tumors
Expand
Head and Neck Tumors
WHO Classification of Tumors of the Urinary System and Male Genital Organs (2016)
WHO Classification of Tumors of Endocrine Organs
Expand
Endocrine Tumors
WHO Classification of Tumors of the Lung, Pleura, Thymus and Heart (2015)
WHO Classification of Tumors of Female Reproductive Organs (2014)
WHO Classification of Tumors of Soft Tissue and Bone (2013)
WHO Classification of Tumors of the Breast (2012)
Expand
Breast Tumors
WHO Classification of Tumours of the Digestive System (2010)
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (2008)
Miscellaneous Cancer Types
Expand
Miscellaneous Tumors